) need to be excluded from this study in our original project design. However, these patients were not excluded in our published paper (Asian Pac J Cancer Prev.2015;16:661-666.), and all the data need to be revised. As a result, the original conclusions have been compromised, especially in the patients with double-negative (postoperative CA19-9 ≤ 37 U/mL and no lymph node metastasis). We are so sorry for this mistake.
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